Delineation of antigen-specific and antigen-nonspecific CD8(+) memory T-cell responses after cytokine-based cancer immunotherapy.
about
Differential phenotypes of memory CD4 and CD8 T cells in the spleen and peripheral tissues following immunostimulatory therapy.Diacylglycerol Kinase ζ Limits Cytokine-dependent Expansion of CD8+ T Cells with Broad Antitumor Capacity.Bystander activation and anti-tumor effects of CD8+ T cells following Interleukin-2 based immunotherapy is independent of CD4+ T cell help.Increased antitumor effects using IL-2 with anti-TGF-β reveals competition between mouse NK and CD8 T cells.Accumulation of memory precursor CD8 T cells in regressing tumors following combination therapy with vaccine and anti-PD-1 antibody.Engagement of NKG2D on bystander memory CD8 T cells promotes increased immunopathology following Leishmania major infectionOut-of-Sequence Signal 3 Paralyzes Primary CD4(+) T-Cell-Dependent Immunity.Late administration of murine CTLA-4 blockade prolongs CD8-mediated anti-tumor effects following stimulatory cancer immunotherapy.Distinct activation thresholds of human conventional and innate-like memory T cells.In vitro-activated tumor-specific T lymphocytes prolong the survival of patients with advanced gastric cancer: a retrospective cohort studyImmunoediting and antigen loss: overcoming the achilles heel of immunotherapy with antigen non-specific therapiesGeneration of a dual-functioning antitumor immune response in the peritoneal cavityAging predisposes to acute inflammatory induced pathology after tumor immunotherapy.The IL-15-based superagonist ALT-803 promotes the antigen-independent conversion of memory CD8(+) T cells into innate-like effector cells with antitumor activity.Efficacy and mechanism-of-action of a novel superagonist interleukin-15: interleukin-15 receptor αSu/Fc fusion complex in syngeneic murine models of multiple myelomaThe role of antigen-specific and non-specific immunotherapy in the treatment of cancer.Cancer immunotherapy: activating innate and adaptive immunity through CD40 agonists.Immunoregulatory pathways following strong inflammatory processes markedly impair CD4+ T cell responses.IL-12 Signals through the TCR To Support CD8 Innate Immune Responses.Specificity may be overrated in cancer immunotherapy: Getting to know the nonspecific side of memory T CellsVisualization of granzyme B-expressing CD8 T cells during primary and secondary immune responses to Listeria monocytogenes.Influenza infection results in local expansion of memory CD8(+) T cells with antigen non-specific phenotype and function.Blockade of BAFF Receptor BR3 on T Cells Enhances Their Activation and Cytotoxicity.In vasculitis of small muscular arteries, activation of vessel-infiltrating CD8 T cells seems to be antigen-independent.Clinical significance of immunotherapy with combined three kinds of cells for operable colorectal cancer.
P2860
Q33572965-7C3AA913-039C-4CC0-B3E5-1544B09B012EQ33715829-EA88A053-6AEE-44AC-9FEC-CDFE2CF96852Q34041058-EBE0D15A-511D-4EE8-A5E9-7FC01DDEC586Q34563034-787BF8BC-9528-425C-93E8-B7B6509A6A07Q35036388-82368A17-FD5C-4015-99DD-7468356365B9Q35105666-161D4B7E-211C-47F0-B0E6-39D3A3C233DBQ36630011-D489CA2C-4713-42A7-B442-72F7D6A0AAF3Q36663524-0107EC9E-1104-4E60-998C-AB1F9206DC0DQ37016414-63E05ADA-27BD-4A79-AD1A-80261538DE16Q37042451-71269BA6-336B-488F-8293-F486DB7E923FQ37047061-40C6880B-6B61-4CD7-A0EF-3D400BA334B0Q37218249-9F7AA432-7167-4182-AFE3-EDCF9C59BC2FQ37246492-3B7E920C-D765-40E8-B07B-9B71BE770EFBQ37435739-51EE04A4-C69C-4FBA-95AE-F31555D8487AQ37557639-54840D56-E979-4269-83D4-6ABD66C6E43AQ38021845-D796619C-EDF3-485F-A64E-4DF85C636F0AQ38786054-9C0BDCA4-689A-4F3D-865D-2F641FCE2448Q38842515-4E7B427B-B1DF-4AFB-8A4E-8F9EE5930E3AQ40577301-0ED7E3C3-E04E-4ABF-949A-15A275A308F1Q41274673-AB746065-BA73-456F-85C5-86C4400DB521Q41678927-66EC87BD-5380-4C16-AB26-8CE94297F0E5Q42277216-C2D595C5-00B1-422C-AA25-7CC3DDD15C5DQ47198559-0027CE11-3E7A-4146-A6A7-87E4B5A9515EQ48320499-EA040B0E-E5FD-46AF-A901-3834CF418D18Q53586115-14686752-C202-4C71-BE82-1E2F88D4C07F
P2860
Delineation of antigen-specific and antigen-nonspecific CD8(+) memory T-cell responses after cytokine-based cancer immunotherapy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Delineation of antigen-specifi ...... ne-based cancer immunotherapy.
@ast
Delineation of antigen-specifi ...... ne-based cancer immunotherapy.
@en
type
label
Delineation of antigen-specifi ...... ne-based cancer immunotherapy.
@ast
Delineation of antigen-specifi ...... ne-based cancer immunotherapy.
@en
prefLabel
Delineation of antigen-specifi ...... ne-based cancer immunotherapy.
@ast
Delineation of antigen-specifi ...... ne-based cancer immunotherapy.
@en
P2093
P2860
P1433
P1476
Delineation of antigen-specifi ...... ne-based cancer immunotherapy.
@en
P2093
Dan L Longo
Danice E C Wilkins
Gail D Sckisel
Jonathan M Weiss
Julia K Tietze
Kevin W Bruhn
Kory L Alderson
Lewis L Lanier
Myriam N Bouchlaka
P2860
P304
P356
10.1182/BLOOD-2011-07-369736
P407
P577
2012-01-17T00:00:00Z